FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)

View source ↗

Summary

The FDA approved a supplemental application for Cephalexin from AvKare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteomyelitis
• Otitis Media
• Skin and Soft Tissue Infections
• Streptococcal Pharyngitis
• Tonsillitis
• Urinary Tract Infection

Drugs mentioned

• Cephalexin (Cephalexin)

Snippet

SUPPL AP for CEPHALEXIN (CEPHALEXIN)